SBIR/STTR Research Award

Development of an Implantable Trigeminal Nerve Stimulation System for Drug Resist

Award identifier b857f1b088aa91eafa8e2aecfdc77e76276797932bbe4181efae256d9bd77f65Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$1,978,318

Program and phase

SBIR · Phase II

Award year

2015

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
NeuroSigma, Inc.
Proposal award date
2015-09-30
Contract end date
2022-02-28
UEI
Not reported
Solicitation number
PAR12-054
Topic code
101

Research abstract

DESCRIPTIONprovided by applicantEpilepsy affects three million Americans and fifty million people worldwideDrug resistant epilepsyDREaffects over one third of all people with epilepsyand may lead to unemploymentinjuryand deathTrigeminal Nerve StimulationTNSis an emerging neuromodulation therapy for DREwhich has unique advantages over other techniquesTNS can be delivered bilaterallyat high frequenciesand externally or subcutaneously with excellent safety and efficacyUnique to TNS is the ability to identify responders with external TNSeTNSprior to implantation with a permanent subcutaneous systemsTNSWe have recently completed the first ever randomized control trialRCTof external TNSeTNSandquotinsubjects with DREForty percentpercentexperienced greater thanpercent reduction in seizure frequency atweekswith significant improvements in moodBeck Depression InventoryThis human clinical trial provides strong evidence for proof of concept of TNS in DREThe purpose of this SBIR translational research project is to develop an implantable subcutaneous Trigeminal Nerve Stimulation SystemsTNSTMfor the treatment of DREThis project builds upon NeuroSigmaandapos s experience in external Trigeminal Nerve SystemeTNSTMfor which it was awarded an STTR inThis SBIR brings together a unique team of biomedical engineersneuroscientists and neurosurgeons with seminal experience in the development of Trigeminal Nerve StimulationFurthermorewe plan to collaborate with Stellar Technologiesa leading manufacturer of intracranial electrodesand CCCa respected manufacturer of implantable pulse generators and components sincewho has agreed to modify an existing multichannel IPG which meets NeuroSigmaandapos s unique design specifications for sTNS Epilepsy is a common disorderand many people with epilepsy have poorly controlled seizureswhich do not respond to multiple medications and treatmentThis project is designed to develop a new treatment for epilepsy called Trigeminal Nerve StimulationTrigeminal Nerve Stimulation is a promising new treatment for epilepsybecause it is minimally invasivelow cost and has the ability to significantly reduce seizures andimprove mood

Technology keywords

Not reported

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.